Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie N Graff

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Cancer|March 11, 2011
Toward predictors of survival in castration-resistant prostate cancerJulie N Graff, Tomasz M Beer
Cancer|July 3, 2013
The role of C-reactive protein in prostate cancerJulie N Graff, Tomasz M Beer
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|September 10, 2020
Leveraging Veterans Health Administration Clinical and Research Resources to Accelerate Discovery and Testing in Precision OncologyJulie N Graff, Grant D Huang
Oncology (Williston Park, N.Y.)|April 18, 2016
Treatment of Nonmetastatic Castration-Resistant Prostate CancerJia Luo, Tomasz M Beer, Julie N Graff
Oncology (Williston Park, N.Y.)|March 27, 2020
The Relationship Between Checkpoint Inhibitors and the Gut Microbiome and Its Application in Prostate CancerAshray Maniar, Amy E Moran, Julie N Graff
Oncology (Williston Park, N.Y.)|January 12, 2019
Gonadotropin-Releasing Hormone Antagonists in Prostate CancerAdam S Kittai, Jessica Blank, Julie N Graff
JAMA Oncology|November 5, 2016
Should Chemotherapy Be Used in Nonmetastatic Prostate Cancer?Julie N Graff, Joshi J Alumkal, Tomasz M Beer
Oncology (Williston Park, N.Y.)|August 28, 2013
Targeted therapy in prostate cancer: is there hope beyond the androgen receptor?Joshi J Alumkal, Julie N Graff, Tomasz M Beer
Expert Opinion on Pharmacotherapy|February 18, 2015
Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancerJulie N Graff, Max J Gordon, Tomasz M Beer
Urology|February 5, 2013
Complete biochemical (prostate-specific antigen) response to sipuleucel-T with enzalutamide in castration-resistant prostate cancer: a case report with implications for future researchJulie N Graff, Charles G Drake, Tomasz M Beer
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Cancer|March 11, 2011
Toward predictors of survival in castration-resistant prostate cancerJulie N Graff, Tomasz M Beer
Cancer|July 3, 2013
The role of C-reactive protein in prostate cancerJulie N Graff, Tomasz M Beer
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|September 10, 2020
Leveraging Veterans Health Administration Clinical and Research Resources to Accelerate Discovery and Testing in Precision OncologyJulie N Graff, Grant D Huang
Oncology (Williston Park, N.Y.)|April 18, 2016
Treatment of Nonmetastatic Castration-Resistant Prostate CancerJia Luo, Tomasz M Beer, Julie N Graff
Oncology (Williston Park, N.Y.)|March 27, 2020
The Relationship Between Checkpoint Inhibitors and the Gut Microbiome and Its Application in Prostate CancerAshray Maniar, Amy E Moran, Julie N Graff
Oncology (Williston Park, N.Y.)|January 12, 2019
Gonadotropin-Releasing Hormone Antagonists in Prostate CancerAdam S Kittai, Jessica Blank, Julie N Graff
JAMA Oncology|November 5, 2016
Should Chemotherapy Be Used in Nonmetastatic Prostate Cancer?Julie N Graff, Joshi J Alumkal, Tomasz M Beer
Oncology (Williston Park, N.Y.)|August 28, 2013
Targeted therapy in prostate cancer: is there hope beyond the androgen receptor?Joshi J Alumkal, Julie N Graff, Tomasz M Beer
Expert Opinion on Pharmacotherapy|February 18, 2015
Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancerJulie N Graff, Max J Gordon, Tomasz M Beer
Urology|February 5, 2013
Complete biochemical (prostate-specific antigen) response to sipuleucel-T with enzalutamide in castration-resistant prostate cancer: a case report with implications for future researchJulie N Graff, Charles G Drake, Tomasz M Beer
Pageof 8